Shares of ImmuPharma plc (LON:IMM – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.94 ($0.03) and traded as low as GBX 1.47 ($0.02). ImmuPharma shares last traded at GBX 1.48 ($0.02), with a volume of 1,098,569 shares trading hands.
ImmuPharma Price Performance
The firm has a market capitalization of £6.39 million, a price-to-earnings ratio of -153.50 and a beta of 1.55. The business’s 50-day moving average price is GBX 1.76 and its 200 day moving average price is GBX 1.94.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Recommended Stories
- Five stocks we like better than ImmuPharma
- Investing in Commodities: What Are They? How to Invest in Them
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Why Invest in High-Yield Dividend Stocks?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Trading Stocks: RSI and Why it’s Useful
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
